“Global Topical Scar Treatment Market to reach a market value of USD 28.9 Billion by 2030 growing at a CAGR of 9.3%”
The Global Topical Scar Treatment Market size is expected to reach $28.9 billion by 2030, rising at a market growth of 9.3% CAGR during the forecast period.
Consumers in North America are often well-informed about skincare trends and are likely to seek solutions for scar reduction. Therefore, the North America region captured $5,287.0 million revenue in the market in 2022. Individuals in North America can browse and buy various skincare products, including topical scar treatments, through online retail.
Social media platforms, including Instagram, TikTok, and YouTube, provide a global stage for beauty trends and skincare routines. Influencers and beauty enthusiasts often share their skincare journeys, including scar management experiences and increasing visibility and awareness of topical scar treatments. Therefore, the market is expanding significantly due to the influence of social media and beauty trends.
Additionally, seniors often undergo surgical procedures for various health conditions, ranging from joint replacements to cardiac surgeries. Post-surgical scarring is common, creating a demand for scar management solutions, including topical treatments. Thus, because of the increasing number of senior citizens, the market is anticipated to increase significantly.
However, Individuals with lower disposable incomes may struggle to afford high-cost advanced formulations. This can reduce accessibility to effective scar treatments for population segments, impacting market penetration. Consumers are often sensitive to product prices, and high-cost formulations may discourage potential buyers. Thus, high cost can slow down the growth of the market.
The skincare industry, like many others, experienced disruptions in the supply chain due to lockdowns, restrictions on movement, and closure of manufacturing facilities. This impacted the availability of raw materials and the production of scar treatment products. Economic uncertainties and changes in consumer spending patterns affected consumers’ purchasing power, potentially impacting the sales of premium skincare products, including specialized scar treatments. Thus, the COVID-19 pandemic had a moderate effect on the market.
On the basis of end-use, the market is divided into hospitals, clinics, and homecare. In 2022, the hospitals segment dominated the market with 42.6% revenue share. Hospitals frequently use topical scar treatments to manage and minimize scarring resulting from surgical procedures. Scar prevention and reduction are essential aspects of post-operative care.
Based on scar type, the market is classified into atrophic scars, hypertrophic & keloid scars, contracture scars, and stretch marks. The hypertrophic & keloid scars segment acquired 26.5% revenue share in the market in 2022. Hypertrophic & keloid scars are often associated with itching and discomfort.
By product, the market is categorized into creams, gels, silicon sheets, and others. In 2022, the creams segment held 38.1% revenue share in the market. Creams are user-friendly and easy to apply, making them convenient for individuals seeking a hassle-free scar treatment option. This ease of application encourages regular use, which is crucial for the effectiveness of scar treatments.
Free Valuable Insights: Global Topical Scar Treatment Market size to reach USD 28.9 Billion by 2030
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region acquired 27.1% revenue share in the market. Rising disposable income in certain countries within the Asia Pacific region allows consumers to spend more on skincare and cosmetic products, including topical scar treatments.
| Report Attribute | Details |
|---|---|
| Market size value in 2022 | USD 14.3 Billion |
| Market size forecast in 2030 | USD 28.9 Billion |
| Base Year | 2022 |
| Historical Period | 2019 to 2021 |
| Forecast Period | 2023 to 2030 |
| Revenue Growth Rate | CAGR of 9.3% from 2023 to 2030 |
| Number of Pages | 231 |
| Number of Tables | 370 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives |
| Segments covered | Product, Scar Type, End-use, Region |
| Country scope |
|
| Companies Included | Smith & Nephew PLC, Lumenis Be Ltd., Merz Pharma GmbH & Co. KGaA, Sonoma Pharmaceuticals Inc., Molnlycke Health Care AB, Suneva Medical, Inc., Perrigo Company PLC, Cynosure, LLC, Newmedical Technology Inc., Integra LifeSciences Holdings Corporation |
By End-use
By Scar Type
By Product
By Geography
This Market size is expected to reach $28.9 billion by 2030.
Influence of social media and beauty trends are driving the Market in coming years, however, High cost of advanced formulations restraints the growth of the Market.
Smith & Nephew PLC, Lumenis Be Ltd., Merz Pharma GmbH & Co. KGaA, Sonoma Pharmaceuticals Inc., Molnlycke Health Care AB, Suneva Medical, Inc., Perrigo Company PLC, Cynosure, LLC, Newmedical Technology Inc., Integra LifeSciences Holdings Corporation
The expected CAGR of this Market is 9.3% from 2023 to 2030.
The Atrophic Scars segment is generating highest revenue in the Market by Scar Type in 2022; there by, achieving a market value of $10.8 billion by 2030.
The North America region dominated the Market by Region in 2022, and would continue to be a dominant market till 2030; there by, achieving a market value of $10.1 billion by 2030.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 